Salesforce's AI Business Is Growing More Than 200%, but the Stock Is Near a 52-Week Low. Something Has to Give.

Salesforce reported Agentforce ARR of $1.2 billion, up 205% year over year, while fiscal Q1 revenue rose 13% to $11.1 billion and EPS increased 52% to $2.42. The stock is down about 37% in 2026 and trades near a 52-week low, even as management expects organic revenue growth to reaccelerate in the second half of fiscal 2027. The article frames AI as a potential catalyst rather than a threat, but near-term skepticism remains due to slower core growth and weakness in marketing, commerce, and Tableau.

Analysis

The market is treating CRM like a secular casualty, but the setup is more nuanced: the core debate is not whether AI is real, it is whether AI monetization will cannibalize the legacy seat model faster than it expands the installed base. So far the evidence points the other way — the fastest growth is coming from a product that should, in theory, be the most disruptive to per-user software economics, yet the sales cycle data suggests it is still additive to wallet share rather than substitutive. That matters because if AI is being sold inside the existing CRM workflow, it can deepen switching costs and actually improve retention, even if headline seat count growth eventually slows.

The more important second-order effect is margin mix. Near-term AI adoption is likely to compress gross margin via inference and data-layer costs before it shows up cleanly in revenue, which is why investors may be underestimating the path dependency: CRM could post improving product demand while earnings multiples stay capped if operating leverage lags. The key catalyst is not the next quarter’s ARR print, but whether organic growth re-accelerates in the back half of FY27 without relying on acquisition drag; that is the point at which the market will have to re-rate the business from "AI-disrupted legacy software" to "AI distribution layer."

From a positioning standpoint, the stock looks more like a sentiment short than a fundamentals short. The combination of depressed valuation, buyback support, and a still-functioning enterprise pipeline creates a skew where disappointments may be already reflected, while any evidence of seat expansion plus cross-sell into Agentforce could force systematic shorts to cover. The cleaner trade is not outright chasing beta, but expressing a relative view against names where AI spend is more obviously capex-heavy and less obviously revenue-accretive.

The contrarian miss is that Oracle’s weak cash flow is being read as a warning for all software, but CRM’s AI posture is structurally different: it is selling workflow automation on top of an installed base, not building frontier infrastructure. If management is right on reacceleration, the market is likely underpricing the earnings leverage from repurchases and modest multiple expansion; if it is wrong, the downside is slower bleed, not collapse, because the balance sheet and cash generation give the company time to prove the thesis.

Key Decisions for Investors

• Initiate a tactical long CRM position on weakness near the 52-week low, with a 3-6 month horizon; target a re-rating if organic growth inflects, and cut if the next two quarters show seat stagnation plus no improvement in core revenue ex-acquisition.
• Structure a pair trade: long CRM / short ORCL for 1-2 quarters; CRM has a clearer path to AI monetization through software workflow, while ORCL is more exposed to capital intensity and the market’s skepticism around AI-driven cash conversion.
• Buy CRM Jan-2027 call spreads financed with out-of-the-money puts to capture upside from FY27 reacceleration while limiting exposure to prolonged multiple compression if AI margin drag persists.
• Avoid chasing INFA after the acquisition premium has already been partially realized; instead use it as a monitor for CRM integration risk and data-platform cross-sell effectiveness over the next 2 quarters.
• If CRM closes above its 50-day moving average on improving guides, add to long exposure; if guidance for FY27 second-half reacceleration is reiterated but not supported by bookings, fade rallies rather than holding for a full thesis reset.